Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Lynn Seely currently holds 155,000 shares of Blueprint Medicines Corp (BPMC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lynn Seely has been a net seller of BPMC stock. They have purchased $0 and sold $38.8M worth of shares.
Lynn Seely's most recent insider trade was on Feb 10, 2026, when they sold 155,000 shares at $0.00 per share.
Lynn Seely serves as Executive at Blueprint Medicines Corp (BPMC). They have executed 130 insider transactions totaling $38.8M over their tenure at the company.
Lynn Seely holds the position of Executive at Blueprint Medicines Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Lynn Seely has shown a selling trading pattern, with $0 in total purchases and $38.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Lynn Seely was on Sep 18, 2014, when they sold $1.8M worth of MDVN shares. This transaction involved 17,800 shares at $99.55 per share.
Lynn Seely currently owns 155,000 shares of Blueprint Medicines Corp (BPMC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Lynn Seely's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Lynn Seely has 130 Form 4 filings on record as an insider at Blueprint Medicines Corp.
Set alerts for Lynn Seely and 40,000+ other insiders.